FIELD NOTE / APPROVAL HISTORY
Sermorelin
This page explains what sermorelin is and why its past approval needs context. Earlier approved products are discontinued. A pharmacy-made sermorelin product today is not approved by FDA, the U.S. drug regulator. The older medical uses do not establish results for adult training or aging goals.
NXT LVL may earn money when readers become Promise patients.
Promise prescribes now. A licensed U.S. provider reviews each request and decides whether to prescribe. Not everyone qualifies. Compounded medicines are made to order and are not FDA-approved.
U.S. patients only. Availability varies by state and by treatment. Promise does not offer care outside the U.S.
A short version of a natural signal.
Sermorelin is a lab-made copy of part of growth-hormone-releasing hormone. That natural hormone carries a signal from the brain to the pituitary gland, a small gland beneath it. The pituitary releases growth hormone.
A peptide is a short chain of amino acids, the building blocks of proteins. Sermorelin is called a secretagogue because it prompts a gland to release a hormone. It is a signal to the gland, rather than a supply of growth hormone itself.
Read the approval history carefully.
Earlier sermorelin products had approved uses in testing the pituitary's growth-hormone response and in children with a growth-hormone shortage and growth problems. Those products are now discontinued. The FDA records show no approved sermorelin product currently on sale in the U.S.
That history is not an approval for adult recovery, muscle or aging goals. It also does not give FDA approval to a medicine made by a pharmacy today.
Compounding is a separate question.
Compounding means preparing a medicine to order. The ingredient's exact chemical form matters. The earlier approved product contained sermorelin acetate, a specific form of sermorelin. That history does not establish that every form sold as sermorelin may be compounded.
A pharmacy must check the exact ingredient and all applicable rules before deciding whether it may prepare a medicine. The earlier approval does not guarantee a prescription, pharmacy preparation or availability. Compounded sermorelin is not FDA-approved.
Adult research has limits.
Small, short studies in older adults examined hormone responses. Some used sermorelin and some a close variant. They do not establish dependable results for healthy adults seeking changes in training, sleep or body composition.
The children's research involved a diagnosed medical condition. A finding in those children cannot be turned into a promise for an adult with a different goal. The population, exact substance and length of a study all matter.
What belongs in a medical review?
Is the goal a medical condition or a training aim?
A licensed provider considers the health history and evidence for the intended use. Interest alone is not eligibility.
Is there an approved product being supplied?
The earlier approved products are discontinued. A pharmacy-made preparation is not FDA-approved.
What information could a provider need?
The research includes hormone levels and blood-sugar checks. The provider decides which information is needed for an individual; this page sets no testing plan.
Source notes
Put the next step in licensed hands.
A Promise visit starts a request for review. A licensed U.S. provider decides whether to prescribe. Not everyone qualifies, and no particular treatment is promised.
NXT LVL may earn money when readers become Promise patients.
Promise prescribes these peptides now through licensed U.S. providers. A provider reviews every request and decides. Not everyone qualifies.
U.S. patients only. Availability varies by state and by treatment. Promise does not offer care outside the U.S.